115 related articles for article (PubMed ID: 7124290)
1. Thyrotrophin stimulation of adenylate cyclase and iodine uptake in human differentiated thyroid cancer.
Thomas-Morvan C; Carayon P; Schlumberger M; Vignal A; Tubiana M
Acta Endocrinol (Copenh); 1982 Sep; 101(1):25-31. PubMed ID: 7124290
[TBL] [Abstract][Full Text] [Related]
2. [Stimulation of adenyl cyclase and fixation of iodine in human cancerous thyroid cells in culture].
Thomas-Morvan C
C R Acad Sci III; 1985; 301(10):487-90. PubMed ID: 3004675
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin regulation of adenylate cyclase activity in human thyroid neoplasms.
Clark OH; Gerend PL
Surgery; 1985 May; 97(5):539-46. PubMed ID: 2986305
[TBL] [Abstract][Full Text] [Related]
4. Stimulatory effect of vasoactive intestinal polypeptide on human normal and neoplastic thyroid tissue.
Siperstein AE; Miller RA; Clark OH
Surgery; 1988 Dec; 104(6):985-91. PubMed ID: 2848326
[TBL] [Abstract][Full Text] [Related]
5. TSH binding correlates with TSH-stimulated thyroid adenylate cyclase activity in human thyroid tissues.
Duh QY; Siperstein AE; Miller RA; Smeds S; Clark OH
Surgery; 1989 Dec; 106(6):967-73; discussion 973-4. PubMed ID: 2588124
[TBL] [Abstract][Full Text] [Related]
6. Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity.
Carayon P; Thomas-Morvan C; Castanas E; Tubiana M
J Clin Endocrinol Metab; 1980 Oct; 51(4):915-20. PubMed ID: 7419673
[TBL] [Abstract][Full Text] [Related]
7. Cell kinetics, DNA content and TSH receptor-adenylate cyclase system in differentiated thyroid cancer.
Chang TC; Kuo SH; Liaw KY; Chang CC; Chen FW
Clin Endocrinol (Oxf); 1988 Nov; 29(5):477-84. PubMed ID: 3253029
[TBL] [Abstract][Full Text] [Related]
8. Effects of thyroid-stimulating hormone on adenyl cyclase activity and intermediary metabolism of "cold" thyroid nodules and normal human thyroid tissue.
DeRubertis F; Yamashita K; Dekker A; Larsen PR; Field JB
J Clin Invest; 1972 May; 51(5):1109-17. PubMed ID: 4341502
[TBL] [Abstract][Full Text] [Related]
9. Effects of thyroid-stimulating hormone on human thyroid carcinoma and adjacent normal tissue.
Field JB; Bloom G; Chou MC; Kerins ME; Larsen PR; Kotani M; Kariya T; Dekker A
J Clin Endocrinol Metab; 1978 Nov; 47(5):1052-8. PubMed ID: 233688
[TBL] [Abstract][Full Text] [Related]
10. Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma.
Abe Y; Ichikawa Y; Muraki T; Ito K; Homma M
J Clin Endocrinol Metab; 1981 Jan; 52(1):23-8. PubMed ID: 6256403
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue.
Clark OH; Gerend PL; Goretzki P; Nissenson RA
J Clin Endocrinol Metab; 1983 Jul; 57(1):140-7. PubMed ID: 6304132
[TBL] [Abstract][Full Text] [Related]
12. Thyrotropin receptor-adenylate cyclase system in Hurthle cell neoplasms.
Clark OH; Gerend PL
J Clin Endocrinol Metab; 1985 Oct; 61(4):773-8. PubMed ID: 2993348
[TBL] [Abstract][Full Text] [Related]
13. Thyrotropin receptor-adenylate cyclase system in plasma membranes from normal and diseased human thyroid glands.
Carayon P; Guibout M; Lissitzky S
J Endocrinol Invest; 1978 Oct; 1(4):321-8. PubMed ID: 229150
[TBL] [Abstract][Full Text] [Related]
14. Thyrotropin receptor-adenylate cyclase function in human thyroid neoplasms.
Saltiel AR; Powel-Jones CH; Thomas CG; Nayfeh SN
Cancer Res; 1981 Jun; 41(6):2360-5. PubMed ID: 6263464
[TBL] [Abstract][Full Text] [Related]
15. Dissociation in the response of the adenylate cyclase system to thyrotropin and prostaglandin E2 in human thyroid carcinoma tissue.
Arcangeli P; Toccafondi R; Rotella CM; Aterini S; Tanini A; Borelli D; Loddi L
Cancer; 1981 Aug; 48(3):757-61. PubMed ID: 6265058
[TBL] [Abstract][Full Text] [Related]
16. Desensitization of cyclic adenosine 3,5'-monophosphate response to thyrotropin in normal and primary or metastatic papillary thyroid cancer cells in vitro.
Tezelman S; Siperstein AE; Duh QY; Wong MG; Clark OH
Surgery; 1996 Dec; 120(6):926-33. PubMed ID: 8957475
[TBL] [Abstract][Full Text] [Related]
17. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
[TBL] [Abstract][Full Text] [Related]
18. Thyrotrophin receptors, tumour radioiodine concentration and thyroglobulin secretion in differentiated thyroid cancers.
Edmonds CJ; Kermode JC
Br J Cancer; 1985 Oct; 52(4):537-41. PubMed ID: 2998424
[TBL] [Abstract][Full Text] [Related]
19. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
[TBL] [Abstract][Full Text] [Related]
20. Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma.
Moog F; Linke R; Manthey N; Tiling R; Knesewitsch P; Tatsch K; Hahn K
J Nucl Med; 2000 Dec; 41(12):1989-95. PubMed ID: 11138683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
